Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Astrocyte-to-neuron conversion is a regenerative strategy that aims to transform astrocytes, a type of glial cell in the CNS, directly into functional neurons. This can be achieved through direct reprogramming (transdifferentiation) or by inducing dedifferentiation followed by redifferentiation. Key methods involve overexpressing specific transcription factors (e.g., NeuroD1, Ascl1, Lmx1a, Dlx2, Myt1/Myt1l, Neurod4, Chd7), using microRNAs (e.g., miR-218), or employing gene editing tools (e.g., CRISPR-CasRx targeting Ptbp1). Successful conversion can lead to neuronal maturation, integration into existing neural circuits, and functional improvements after CNS injury in animal models. However, the efficiency and specificity of conversion, as well as potential off-target effects and long-term stability, remain important considerations.
Direct reprogramming/transdifferentiation via transcription factors, microRNAs, or gene editing to convert astrocytes into functional neurons.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Astrocyte-to-Neuron Conversion.